Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 335

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Vitamin D: a pleiotropic hormone

Open access
Verstuyf, Annemieke, Carmeliet, Geert, Bouillon, Roger, Mathieu, Chantal·2010·Kidney International
DOI 10.1038/ki.2010.17
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ki.2010.17

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 38

  1. Bouillon, 2008, Vitamin D and human health: lessons from vitamin D receptor null mice, Endocr Rev, 29, 726, 10.1210/er.2008-0004 · DOI · Paper page
  2. Xue, 2009, Intestinal vitamin D receptor is required for normal calcium and bone metabolism in mice, Gastroenterology, 136, 1317, 10.1053/j.gastro.2008.12.051 · DOI
  3. Lieben, 2008, Intestinal-Specific Vitamin D receptor null mice maintain normal calcemia but display severe bone loss, J Bone Miner Res, 23, S104
  4. Van Cromphaut, 2001, Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects, Proc Natl Acad Sci USA, 98, 13324, 10.1073/pnas.231474698 · DOI · Paper page
  5. Bianco, 2007, Marked disturbance of calcium homeostasis in mice with targeted disruption of the Trpv6 calcium channel gene, J Bone Miner Res, 22, 274, 10.1359/jbmr.061110 · DOI · Paper page
  6. Benn, 2008, Active intestinal calcium transport in the absence of transient receptor potential vanilloid type 6 and calbindin-D9k, Endocrinology, 149, 3196, 10.1210/en.2007-1655 · DOI
  7. Fujita, 2008, Tight junction proteins claudin-2 and -12 are critical for vitamin D-dependent Ca2+ absorption between enterocytes, Mol Biol Cell, 19, 1912, 10.1091/mbc.E07-09-0973 · DOI · Paper page
  8. Hoenderop, 2003, Renal Ca2+ wasting, hyperabsorption, and reduced bone thickness in mice lacking TRPV5, J Clin Invest, 112, 1906, 10.1172/JCI200319826 · DOI · Paper page
  9. Masuyama, 2006, Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts, J Clin Invest, 116, 3150, 10.1172/JCI29463 · DOI · Paper page
  10. Naja, 2009, Chondrocyte-specific modulation of CYP27B1 expression supports a role for local synthesis of 1,25-dihydroxyvitamin D3 in growth plate development, Endocrinology, 150, 4024, 10.1210/en.2008-1410 · DOI
  11. Sooy, 2005, Osteoblasts lacking the vitamin D receptor display enhanced osteogenic potential in vitro, J Cell Biochem, 94, 81, 10.1002/jcb.20313 · DOI
  12. Gardiner, 2000, Increased formation and decreased resorption of bone in mice with elevated vitamin D receptor in mature cells of the osteoblastic lineage, FASEB J, 14, 1908, 10.1096/fj.99-1075com · DOI
  13. Meir, 2009, Deletion of the vitamin D receptor specifically in the parathyroid demonstrates a limited role for the VDR in parathyroid physiology, Am J Physiol Renal Physiol, 297, F1192, 10.1152/ajprenal.00360.2009 · DOI
  14. van der Wielen, 1995, Serum vitamin D concentrations among elderly people in Europe, Lancet, 346, 207, 10.1016/S0140-6736(95)91266-5 · DOI · Paper page
  15. Yin, 2009, Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk, Aliment Pharmacol Ther, 30, 113, 10.1111/j.1365-2036.2009.04022.x · DOI
  16. Gorham, 2007, Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis, Am J Prev Med, 32, 210, 10.1016/j.amepre.2006.11.004 · DOI
  17. Bertone-Johnson, 2005, Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer, Cancer Epidemiol Biomarkers Prev, 14, 1991, 10.1158/1055-9965.EPI-04-0722 · DOI
  18. Colston, 2008, Vitamin D and breast cancer risk, Best Pract Res Clin Endocrinol Metab, 22, 587, 10.1016/j.beem.2008.08.002 · DOI
  19. Travis, 2009, Serum vitamin D and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition (EPIC), Am J Epidemiol, 169, 1223, 10.1093/aje/kwp022 · DOI
  20. Wactawski-Wende, 2006, Calcium plus vitamin D supplementation and the risk of colorectal cancer, N Engl J Med, 354, 684, 10.1056/NEJMoa055222 · DOI · Paper page
  21. Lappe, 2007, Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial, Am J Clin Nutr, 85, 1586, 10.1093/ajcn/85.6.1586 · DOI · Paper page
  22. Wang, 2009, MicroRNAs181 regulate the expression of p27Kip1 in human myeloid leukemia cells induced to differentiate by 1,25-dihydroxyvitamin D3, Cell Cycle, 8, 736, 10.4161/cc.8.5.7870 · DOI
  23. Verlinden, 2007, 1alpha,25-Dihydroxyvitamin D3-induced down-regulation of the checkpoint proteins, Chk1 and Claspin, is mediated by the pocket proteins p107 and p130, J Steroid Biochem Mol Biol, 103, 411, 10.1016/j.jsbmb.2006.12.080 · DOI
  24. Deeb, 2007, Vitamin D signalling pathways in cancer: potential for anticancer therapeutics, Nat Rev Cancer, 7, 684, 10.1038/nrc2196 · DOI · Paper page
  25. Medioni, 2009, Dose finding and safety analysis of inecalcitol in combination with a docetaxel-prednisone regimen in hormone-refractory prostate cancer (HRPC) patients, J Clin Oncol, 155, 5151, 10.1200/jco.2009.27.15_suppl.5151 · DOI
  26. Lehmann, 2005, The vitamin D3 pathway in human skin and its role for regulation of biological processes, Photochem Photobiol, 81, 1246, 10.1562/2005-02-02-IR-430 · DOI
  27. Baeke, 2008, Vitamin D signaling in immune-mediated disorders: evolving insights and therapeutic opportunities, Mol Aspects Med, 29, 376, 10.1016/j.mam.2008.05.004 · DOI
  28. Sigmundsdottir, 2007, DCs metabolize sunlight-induced vitamin D3 to ‘program’ T cell attraction to the epidermal chemokine CCL27, Nat Immunol, 8, 285, 10.1038/ni1433 · DOI · Paper page
  29. Adorini, 2009, Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists, Hum Immunol, 70, 345, 10.1016/j.humimm.2009.01.016 · DOI
  30. Yu, 2008, Failure of T cell homing, reduced CD4/CD8alphaalpha intraepithelial lymphocytes, and inflammation in the gut of vitamin D receptor KO mice, Proc Natl Acad Sci USA, 105, 20834, 10.1073/pnas.0808700106 · DOI
  31. Adorini, 2004, Pharmacological induction of tolerogenic dendritic cells and regulatory T cells, Semin Immunol, 16, 127, 10.1016/j.smim.2003.12.008 · DOI
  32. Mathieu, 2005, Vitamin D and diabetes, Diabetologia, 48, 1247, 10.1007/s00125-005-1802-7 · DOI · Paper page
  33. Cantorna, 2008, Vitamin D and multiple sclerosis: an update, Nutr Rev, 66, S135, 10.1111/j.1753-4887.2008.00097.x · DOI
  34. Munger, 2006, Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis, JAMA, 296, 2832, 10.1001/jama.296.23.2832 · DOI · Paper page
  35. Bouillon, 2009, Vitamin D as potential baseline therapy for blood pressure control, Am J Hypertens, 22, 816, 10.1038/ajh.2009.105 · DOI
  36. Schmitz, 2009, Association of 25-hydroxyvitamin D with blood pressure in predominantly 25-hydroxyvitamin D deficient Hispanic and African Americans, Am J Hypertens, 22, 867, 10.1038/ajh.2009.88 · DOI
  37. Margolis, 2008, Effect of calcium and vitamin D supplementation on blood pressure: the Women's Health Initiative Randomized Trial, Hypertension, 52, 847, 10.1161/HYPERTENSIONAHA.108.114991 · DOI
  38. Hagenau, 2009, Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis, Osteoporos Int, 20, 133, 10.1007/s00198-008-0626-y · DOI · Paper page

Cited by

See all 335

Metadata

Authors
Verstuyf, A., Carmeliet, G., Bouillon, R., & Mathieu, C.
Venue
Kidney International
Publisher
Elsevier BV
Published
2010-07
Volume
78
Issue
2
Pages
140-145
ISSN
0085-2538 (ISSN-L)
DOI
10.1038/ki.2010.17
OpenAlex
W1978131786
Cited by
335
References
3
FWCI
15.00
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.